Home
Sanofi

Sanofi Market Share Analysis for July 2026

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo.

Health > Biotechnology and Pharmaceuticals

Domainsanofi.cn

Year Founded1973

Employees> 10001

Annual Revenue> $1B

Sanofi

Sanofi (including company regionals)

sanofi.cn

See more website traffic and engagement information

Sanofi Revenue up to July 2026 is > 1B

revenue generated by Sanofi top domains

Sanofi top domains revenue over 3 years

Revenue for Sanofi top domains

sanofi.cn> 1B

See more with Sales Intelligence

Sanofi Stock price in July 2026

Sanofi stock is traded under the ticker #SNY. Below you can review Sanofi stock performance in the past 12 months up to July 2026

Total visits to Sanofi's top domains

Understand Sanofi market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sanofi.cn11.5K

See more with Sales Intelligence

Avg. visit duration in Sanofi's top domains

Analyze Sanofi engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sanofi.cn00:00:18

See more with Sales Intelligence

Avg. pageviews on Sanofi's top domains

See how Sanofi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sanofi.cn1.51

See more with Sales Intelligence

Sanofi top competitors by domain

Top similar sites in July 2026, ranked by their affinity

nmpa.gov.cnCompany NameNational Medical Products AdministrationEmployees> 10001HQChina, BeijingAnnual revenue--Total visits1.3MHealth > Pharmacy

Top technologies used by Sanofi

These are the website technologies, by industry, used by Sanofi top domains

Conversion & Analytics (4)

Google Analytics

Social (4)

Instagram

Advertising (3)

DoubleClick

Audio Video Media (3)

YouTube

More Technologies

8

See all

News & Signals from Sanofi

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSanofi partners with Innovent GmbH.Sanofi also announced a strategic collaboration in oncology with Innovent, aiming to accelerate oncology product development and access and bring innovative drugs to more Chinese patients.

NewsSanofi is developing SAR408701.Sanofi granted Innovent exclusive rights to develop and commercialize SAR408701 (tusamitamab ravtansine), a Phase III anti-CEACAM5 antibody-drug conjugate for the treatment of non-small cell lung cancer (NSCLC) and gastric cancer in China.

NewsSanofi partnered with Innovent Biologics on May 8th '22.Sanofi and Innovent Biologics have announced a collaboration that will bring innovative medicines to patients in China with difficult-to-treat cancers.